CDx Diagnostics to Unveil New Data Demonstrating a Significant Advance in the Prevention of the Most Rapidly Growing Cancer in the U.S.

SUFFERN, NY–(Marketwired – May 17, 2016) –  CDx Diagnostics today announced that results from a multi-center, prospective, randomized clinical trial demonstrating that WATS^3D (Wide Area Transepithelial Sampling with 3D Tissue Analysis) sharply increases the detection of esophageal dysplasia (precancer), will be presented at Digestive Disease Week® 2016 (DDW), taking place from May 21-24 in San Diego, Calif
http://www.marketwired.com/press-release/cdx-diagnostics-unveil-new-data-demonstrating-significant-advance-prevention-most-rapidly-2125738.htm